MARKET

DYMDF

DYMDF

Diamyd Med Share
Grey
1.850
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
1.850
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.873
52 WEEK LOW
1.630
MARKET CAP
247.89M
P/E (TTM)
-11.5987
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DYMDF last week (0908-0912)?
Weekly Report · 09/15 12:33
Weekly Report: what happened at DYMDF last week (0901-0905)?
Weekly Report · 09/08 12:35
Weekly Report: what happened at DYMDF last week (0825-0829)?
Weekly Report · 09/01 12:28
Weekly Report: what happened at DYMDF last week (0818-0822)?
Weekly Report · 08/25 12:46
Weekly Report: what happened at DYMDF last week (0811-0815)?
Weekly Report · 08/18 12:32
Weekly Report: what happened at DYMDF last week (0804-0808)?
Weekly Report · 08/11 12:46
Weekly Report: what happened at DYMDF last week (0728-0801)?
Weekly Report · 08/04 12:49
Weekly Report: what happened at DYMDF last week (0721-0725)?
Weekly Report · 07/28 12:49
More
About DYMDF
Diamyd Medical AB is a Sweden-based diabetes company. It is active in the field of pharmaceutical development and investments in stem cell and medical technology. The Company develops the diabetes vaccine, Diamyd, with the active glutamic acid decarboxylase (GAD) ingredient for the treatment and prevention of autoimmune diabetes. The vaccine is intended for the treatment of children and adolescents with recent-onset type one diabetes, as well as those at high risk of developing the disease.

Webull offers Diamyd Medical AB stock information, including Grey: DYMDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYMDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYMDF stock methods without spending real money on the virtual paper trading platform.